These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9650536)

  • 1. Use of angiotensin-converting enzyme inhibitors as monotherapy and in combination with diuretics and calcium channel blockers.
    Cheng A; Frishman WH
    J Clin Pharmacol; 1998 Jun; 38(6):477-91. PubMed ID: 9650536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D; Paris BE; Aronow WS
    J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
    Morgan TO; Anderson AI; MacInnis RJ
    Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: effectiveness in combination with diuretics or beta-blockers for treating hypertension.
    Bisognano JD; McLaughlin T; Roberts CS; Tang SS
    Vasc Health Risk Manag; 2007; 3(5):579-85. PubMed ID: 18078009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of converting enzyme inhibitors, calcium channel blockers and diuretics.
    Sinaiko AR
    J Hum Hypertens; 1994 May; 8(5):389-94. PubMed ID: 8064788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial.
    Suliburska J; Skrypnik K; Szulińska M; Kupsz J; Markuszewski L; Bogdański P
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30208601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Which drugs are better in patients with diabetes? Meaningfulness of data on hypertensive drugs in diabetes is limited].
    Zidek W
    Dtsch Med Wochenschr; 2014 Jan; 139(1-2):16. PubMed ID: 24390845
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative pharmacokinetic and clinical profiles of angiotensin-converting enzyme inhibitors and calcium antagonists in systemic hypertension.
    Frishman WH
    Am J Cardiol; 1992 Apr; 69(10):17C-25C. PubMed ID: 1546635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kidney and hypertension--evidence based medicine].
    Nakao N; Senou H; Kasuga H; Toriyama T; Kawahara H
    Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1639-45. PubMed ID: 15384696
    [No Abstract]   [Full Text] [Related]  

  • 13. Fixed dose combinations of ACE inhibitors.
    Rangoonwala B; Schulz W; Bauer B
    Br J Clin Pract; 1996 Dec; 50(8):454-65. PubMed ID: 9039718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Palmer CR; Brown MJ; Mancia G; Ruilope LM;
    JAMA; 2003 Apr 23-30; 289(16):2066-7; author reply 2069-70. PubMed ID: 12709455
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Yarows SA
    JAMA; 2003 Apr 23-30; 289(16):2068-9; author reply 2069-70. PubMed ID: 12709458
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibitors in perspective: an update.
    Burrell LM; Johnston CI
    Aust Fam Physician; 1993 Jul; 22(7):1243-7, 1251, 1255. PubMed ID: 8373316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.
    Donnelly R; Molyneaux LM; Willey KA; Yue DK
    Am J Cardiol; 1996 Feb; 77(6):26B-30B. PubMed ID: 8848991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Messerli FH; Weber MA
    JAMA; 2003 Apr 23-30; 289(16):2067-8; author reply 2069-70. PubMed ID: 12709457
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Ong HT
    JAMA; 2003 Apr 23-30; 289(16):2068; author reply 2069-70. PubMed ID: 12709460
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Chikamori T
    JAMA; 2003 Apr 23-30; 289(16):2066; author reply 2069-70. PubMed ID: 12709456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.